Full Description
The first critical analysis of how Whiteness drove the opioid crisis.
In the past two decades, media images of the surprisingly white "new face" of the US opioid crisis abounded. But why was the crisis so white? Some argued that skyrocketing overdoses were "deaths of despair" signaling deeper socioeconomic anguish in white communities. Whiteout makes the counterintuitive case that the opioid crisis was the product of white racial privilege as well as despair.
Anchored by interviews, data, and riveting firsthand narratives from three leading experts—an addiction psychiatrist, a policy advocate, and a drug historian—Whiteout reveals how a century of structural racism in drug policy, and in profit-oriented medical industries led to mass white overdose deaths. The authors implicate racially segregated health care systems, the racial assumptions of addiction scientists, and relaxed regulation of pharmaceutical marketing to white consumers. Whiteout is an unflinching account of how racial capitalism is toxic for all Americans.
Contents
Contents
List of Illustrations
Acknowledgments
Time Line
PART ONE. TECHNOLOGIES OF WHITENESS IN THE CLINIC, THE STATEHOUSE, AND THE ARCHIVE
1. Pharmakon of Racial Poisons and Cures
(as told by Helena Hansen, psychiatrist-anthropologist)
2. How to See Whiteness
(as told by all three authors)
3. Good Samaritans in the War on Drugs That Wasn't
(as told by Jules Netherland, policy analyst)
4. "Mother's Little Helpers": White Narcotics in the Medicine Cabinet
(as told by David Herzberg, historian)
PART TWO. THREE OPIODS: RACIAL BIOGRAPHIES
5. OxyContin's Racial Precision
6. Buprenorphine's Silent White Revolution
7. The Housewife's Return to Heroin (and Forays into
Fentanyl)
8. From Racial Capitalism to Biosocial Justice
Glossary
Notes
Bibliography
Index
